Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds, particularly in the development of kinase inhibitors. Shows potential in medicinal chemistry for designing drugs targeting inflammatory diseases and certain cancers due to its imidazoquinoxaline scaffold, which exhibits strong binding affinity to specific enzyme receptors. Also employed in the study of structure-activity relationships (SAR) for optimizing drug candidates with improved metabolic stability and selectivity.